Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesCurrent progress in the pharmacological therapy of fibromyalgia
Expert Opinion on Investigational Drugs, 09/18/09
Rao SG – Recent research advances highlight a critical role for aberrant central pain processing in FM, and, consistent with these data, the first three drugs approved by the FDA for FM over the past 2 years have a predominantly central mode of action. The first drug, pregabalin, may counteract central pain transmission by inhibiting presynaptic release of excitatory neurotransmitters, including substance P and glutamate. The serotonin–norepinephrine reuptake inhibitors duloxetine and milnacipran have been approved more recently and are believed to reduce pain by increasing serotonin and norepinephrine concentrations in descending inhibitory pain pathways. Agents with multiple other mechanisms of action are in development and promise an assortment of therapeutic options for this complex disorder in the near future.
Related Articles
Sexual disorder improvement: a target or a way in treatment of fibromyalgia. A case report and brief review
Modern Rheumatology, 10/07/09
Relevance Score: 87%
Review: limited evidence that psychological therapies are of benefit for adults with chronic pain
Evidence-Based Mental Health, 10/28/09
Relevance Score: 86%
Accuracy of reporting current medications by cancer patients presenting to an emergency center
Supportive Care in Cancer, 11/11/09
Relevance Score: 81%
Fibromyalgia: Influence of Depressive Symptoms on the Outcome after Rehabilitation
Die Rehabilitation, 10/29/09
Relevance Score: 80%
Fibromyalgia and Myofascial Pain Syndrome - A Dilemma
Indian Journal of Anaesthesia, 10/22/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Pharmacist and physician collaborative prescribing: For medication renewals within a primary health centre
Canadian Family Physician, 12/16/09
Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications: Opinions of Saskatchewan family physicians
Canadian Family Physician, 12/16/09
Taking the stress out of managing gout
Canadian Family Physician, 12/16/09
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Prevalence of Multiple Sclerosis in 3 US Communities
Preventing Chronic Disease, 12/16/09
Effects of topiramate on neurophysiological and neuropsychological tests in migraine patients
Journal of Clinical Neuroscience, 12/16/09
Acetazolamide and midazolam act synergistically to inhibit neuropathic pain
Pain, 12/16/09
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Taking the stress out of managing gout
Canadian Family Physician, 12/16/09
Lymphatic and blood vessels in scleroderma skin, a morphometric analysis
Human Pathology, 12/16/09
Predictors of Damage and Survival in Patients with Wegener's Granulomatosis: Analysis of 50 Patients
Journal of Rheumatology, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor